Finnrick, an independent testing programme, publishes 6 assays for VIP Wellness Access: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 3 did not. Most recent assay 22 Jun 2026.
VIP Wellness Access listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/vip-wellness-access.
Listed in the Finnrick vendor directory. Not yet tested.
VIP Wellness Access is listed as active. Tracked by Finnrick. No test data available yet.
No independent third-party assay is on file for VIP Wellness Access, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 6 | 2 passed, 3 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
VIP Wellness Access is listed as active and we hold 6 Finnrick assays (2 passing, 3 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 6 assays for VIP Wellness Access: 2 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 3 did not. Most recent assay 22 Jun 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: VitalCell Peptides Review, VitaPeptide Review, Vitralab Research Peptides Review.